I am closing out our position in Cardinal Health with a 15% increase over the past three months. Read More

Our model tells us that this is a stock in transition that could easily see a big expansion in its earnings multiple once it turns positive. Read More

My guess is the same elements that worked in SNI’s favor during the third quarter – healthy growth in advertising sales and distribution revenues – will work against it this time. Read More

Gilead's weak quarterly report released after the close on Tuesday pushed its share price down 10% yesterday, closing beneath our stop price of $68. Read More

Cardinal soars, while Gilead and USANA head south Read More

This alert was triggered by the most technical component of our Rapid Profits Matrix, which looks for “fallen angels” that are bottoming out. Read More

CVS’ s cash flow from operations grew by 15% (YOY) during the most recent quarter and earnings grew by 23%, so my IDEAL Stock Rating System now rates it as a strong buy. Read More

I think DHI is due for another swing to the upside based on its recent share price behavior, and its high scores from our RPM and IDEAL Stock Rating System. Read More

There are two mitigating factors that have convinced me to close out this trade at a small loss. Read More

According to our RPM Kohl's is now oversold and likely to bounce back soon. Read More